Skip to main content
. Author manuscript; available in PMC: 2012 Jan 1.
Published in final edited form as: Microcirculation. 2011 Jan;18(1):36–45. doi: 10.1111/j.1549-8719.2010.00066.x

Figure 3.

Figure 3

Effect of L-arginine and DFMO on vasomotor function. A: Coronary arteriolar dilation to serotonin (Control; n=8) was not altered in the presence of L-arginine (3 mM; n=4) or DFMO (0.4 mM; n=4). B: Coronary arteriolar dilation in response to sodium nitroprusside (Control; n=14) was not altered by OxLDL (0.5 mg protein/ml; n=5), L-arginine (L-Arg, 3 mM; n=4), or DFMO (0.4 mM; n=5).